Information de reference pour ce titreAccession Number: | 01451459-199908000-00042.
|
Author: | Gottfredsson, Magnus; Cox, Gary M.; Indridason, Olafur S.; de Almeida, Gisele M. D. a; Heald, Alison E.; Perfect, John R.
|
Institution: | Department of Medicine, Division of Infectious Diseases and International Health and Nephrology, Duke University Medical Center, Durham, North Carolina
|
Title: | |
Source: | Journal of Infectious Diseases. 180(2):534-537, August 1999.
|
Abstract: | : The pathophysiology of oropharyngeal candidiasis in patients infected with human immunodeficiency virus (HIV) type 1 is poorly understood. Association between oropharyngeal yeast carriage and various clinical factors in HIV-1-infected patients was studied in 83 patients with no clinical evidence of thrush and no recent antifungal use. Of the clinical factors measured, the only correlate of yeast colonization was with plasma HIV-1 RNA levels (P = .001), whereas the correlation with CD4 cell count was poor (P =.36). By multivariable regression modeling, plasma HIV-1 RNA was the only parameter that correlated with the extent of colonization with Candida infection (P =.003). These data indicate that the presence and amount of asymptomatic oropharyngeal yeast carriage in persons with HIV-1 infection is more significantly correlated with plasma HIV-1 RNA levels than with CD4 cell count. Further studies on the effect of HIV-1 on oropharyngeal yeast colonization, infection, and local immunity are warranted.
(C) Copyright Oxford University Press 1999.
|
References: | 1. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991; 5:519-25.
2. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327:1697-703.
3. Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994; 97:339-46.
4. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-9.
5. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 1998; 280:72-7.
6. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration: multicenter AIDS cohort study investigators. JAMA 1998; 280:1497-503.
7. Bergbrant IM, Faergemann J. Quantitative cultures of Candida from mouthwash fluid in HIV-infected patients: a longitudinal study. Mycoses 1997; 40:377-80.
8. Kinloch-De LoesS, Hirschel B, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995; 333:408-13.
9. Hood S, Bonington A, Evans J, Denning D. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors. AIDS 1998; 12:447-8.
10. Valdez H, Gripshover BM, Salata RA, Lederman MM. Resolution of azoleresistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy. AIDS 1998; 12:538.
11. Pietrella D, Monari C, Retini C, Palazzetti B, Bistoni F, Vecchiarelli A. Human immunodeficiency virus 1 envelope protein gp120 impairs intracellular antifungal mechanisms in human monocytes. J Infect Dis 1998; 177:347-54.
12. Gruber A, Lukasser-Vogl E, Borg-von Zepelin M, Dierich MP, Wurzner R. Human immunodeficiency virus type 1 gp1 60 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J Infect Dis 1998; 177:1057-63.
13. Davis SL, Hawkins EP, Mason EOJ, Smith CW, Kaplan SL. Host defenses against disseminated candidiasis are impaired in intracellular adhesion molecule 1-deficient mice. J Infect Dis 1996; 174:435-9.
14. Hostetter M. Adhesins and ligands involved in the interaction of Candida spp with epithelial and endothelial surfaces. Clin Microbiol Rev 1994; 7:29-42.
15. Cenci E, Mencacci A, Spaccapelo R, et al. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995; 171:1279-88.
|
Language: | English.
|
Document Type: | Concise Communications.
|
ISSN: | 0022-1899
|
DOI Number: | https://dx.doi.org/10.1086/31488...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |